Dr. Jedd D. Wolchok is the chief of the Melanoma and
Immunotherapeutics Service, the Lloyd J. Old / Virginia and Daniel K. Ludwig Chair in Clinical Investigation, and director of the Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center.
Dr. Wolchok is the Lloyd J. Old / Virginia and Daniel K. Ludwig Chair in Clinical Investigation at Memorial Sloan Kettering Cancer Center (MSK); chief of the Melanoma and
Immunotherapeutics Service at MSK; and an attending physician at MSK with expertise in the treatment of metastatic melanoma.
Not exact matches
Bilthoven, April 21, 2016 - An international multi-disciplinary consortium of 11 partners, in which 5 leading academic institutes, 4 cutting - edge biotech companies and 2 excellent
service providers will join forces to advance the treatment of cancer using an innovative
immunotherapeutic nanomedicin, has received an $ 8.3 million Horizon 2020 grant (grant agreement No 686089).